Beyond the anti-PD-1/PD-L1 era: promising role of the BTLA/HVEM axis as a future target for cancer immunotherapy

Abstract Recent introduction of monoclonal antibodies targeting immune checkpoints to harness antitumor immunity has revolutionized the cancer treatment landscape. The therapeutic success of immune checkpoint blockade (ICB)-based therapies mainly relies on PD-1/PD-L1 and CTLA-4 blockade. However, th...

全面介紹

書目詳細資料

Principais autores:	Christian Sordo-Bahamonde, Seila Lorenzo-Herrero, Rocío Granda-Díaz, Alejandra Martínez-Pérez, Candelaria Aguilar-García, Juan P. Rodrigo, Juana M. García-Pedrero, Segundo Gonzalez
格式:	Artigo
語言:	Inglês
出版:	BMC 2023-08-01
叢編:	Molecular Cancer
主題:	Immunotherapy BTLA HVEM Checkpoint blockade T cell NK cell
在線閱讀:	https://doi.org/10.1186/s12943-023-01845-4
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!